Real Life Effectiveness of KASA: A Prospective Observational Cohort Study
Phase of Trial: Phase IV
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 31 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Jul 2016 Planned End Date changed from 1 Sep 2016 to 1 Oct 2016.
- 08 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016, according to ClinicalTrials.gov record.